Daniel Gedeon Teper is CEO at IMMUNE PHARMACEUTICALS INC (IMNP). They have made 4 open-market trades across 1 company since 2015, most recently 2016-10-06.
CIK 0001208261
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
4 open-market purchases totalling $665K since 2015, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IMNP | BUY | 2016-08-04 | 2016-08-19 | $0.41 | $356K | +2.0% | -15.3% | -15.3% |
| IMNP | BUY | 2016-01-26 | 2016-01-26 | $0.59 | $25K | +2.0% | -15.3% | -15.3% |
| IMNP | BUY | 2016-01-19 | 2016-01-19 | $0.57 | $25K | +2.0% | -15.3% | -15.3% |
| IMNP | BUY | 2016-01-12 | 2016-01-12 | $0.62 | $24K | +2.0% | -15.3% | -15.3% |
| IMNP | BUY | 2016-01-05 | 2016-01-06 | $0.81 | $50K | +2.0% | -15.3% | -15.3% |
| IMNP | BUY | 2015-12-07 | 2015-12-08 | $0.76 | $50K | +2.0% | -15.3% | -15.3% |
| IMNP | BUY | 2015-10-26 | 2015-10-26 | $1.36 | $25K | +2.0% | -15.3% | -15.3% |
| IMNP | BUY | 2015-10-19 | 2015-10-19 | $1.34 | $25K | +2.0% | -15.3% | -15.3% |
| IMNP | BUY | 2015-10-12 | 2015-10-13 | $1.30 | $25K | +2.0% | -15.3% | -15.3% |
| IMNP | BUY | 2015-10-05 | 2015-10-05 | $1.23 | $50K | +2.0% | -15.3% | -15.3% |
| IMNP | BUY | 2015-09-01 | 2015-09-01 | $1.29 | $10K | +2.0% | -15.3% | -15.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.